Key result
Majority Black communities linked to ~41% lower odds of prehospital aspirin for chest pain versus White communities.
Why the study?
Although disparities exist in aspirin administration for chest pain and STEMI, little is known about community-based disparities in aspirin administration for prehospital patients.
Are there racial, ethnic, and income disparities in prehospital aspirin administration for chest pain and STEMI?
Observational (n=5,066,273)
Yes
Are there racial, ethnic, and income disparities in prehospital aspirin administration for chest pain and STEMI?
Significant racial, ethnic, and socioeconomic disparities exist in the prehospital administration of aspirin for chest pain and STEMI, highlighting inequities in acute cardiovascular care.
Disparities in prehospital aspirin use by race and income warrant attention; hypothesis-generating for equity-focused EMS interventions.
OBJECTIVES: Although disparities exist in aspirin administration for chest pain and ST elevation myocardial infarctions (STEMI), little is known about community-based disparities in aspirin administration for prehospital patients. We evaluated disparities in prehospital aspirin using a national prehospital database. METHODS: We conducted a retrospective analysis of the 2018-2021 NEMSIS database linked to census data, including adult prehospital encounters. We created two cohorts: dispatch reason of chest pain and identified STEMI on prehospital EKG. We stratified patients based on majority ZIP Code race/ethnicity (>50% White, Black, and Hispanic) and into quartiles based on household income. Using multivariable logistic regression, we evaluated the association between incident community characteristics and aspirin administration. RESULTS: We included 4,881,663 chest pain encounters and 184,610 STEMIs. Chest pain encounters in majority White communities (32.3%) received aspirin more often for chest pain than Black (22.1%; aOR 0.59, [0.59-0.60]) or Hispanic (24.8%; aOR 0.66, [0.66-0.67]) communities. Compared to the top income quartile (29.0%), the lowest income quartile had lower odds of aspirin administration (4th-27.6%; aOR 0.93, [0.92-0.94]). For STEMIs, adjusted odds of aspirin administration were higher for White (53.4%) than Black (52.5%; aOR 0.81, [0.78-0.84]) or Hispanic (53.6%; aOR 0.93, [0.89-0.96]) patients. Compared to the highest income quartile (55.0%), lower quartiles had lower odds of aspirin administration (2nd-54.2%; aOR 0.95, [0.92-0.97]; 3rd-52.9%; aOR 0.93, [0.91-0.96]; 4th-52.0%; aOR 0.86, [0.84-0.89]). CONCLUSIONS: Patients from Black, Hispanic/Latino, and lowest-income communities received aspirin for chest pain at a lower rate than white or high-income patients.
No takes yet. Share an insight, caveat, or question.
Johnson et al. (2025) conducted an observational in Prehospital chest pain and STEMI (n=5,066,273). Majority Black or Hispanic community and lower household income vs. Majority White community and highest household income quartile was evaluated on Prehospital aspirin administration for chest pain (aOR 0.59, 95% CI 0.59-0.60). Patients from majority Black communities had lower odds of receiving prehospital aspirin for chest pain compared to White communities (22.1% vs 32.3%; aOR 0.59, 95% CI 0.59-0.60).
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: